The House resolution formally designates September 2025 as National Ovarian Cancer Awareness Month , aiming to increase public and healthcare provider awareness of the disease’s vague symptoms and the need for early detection . It underscores that ovarian cancer is the fifth-leading cause of cancer deaths among women in the United States, with a 5‑year survival rate that drops sharply when diagnosed late. The resolution also points out significant disparities, noting that Black women face higher mortality rates and lower quality care compared to White women. The resolution stresses the absence of a reliable screening test and the fact that about 80% of cases are detected at an advanced stage, which hampers treatment success. It emphasizes the role of family history and genetic testing—particularly BRCA mutations—in identifying high‑risk individuals and encourages prophylactic measures such as opportunistic salpingectomy. The resolution calls for increased federal investment in ovarian cancer research and education to close knowledge gaps identified by the National Academy of Medicine. Finally, it supports ongoing community events and partnerships that promote awareness and early diagnosis during the designated month.